Friend virus induces acute erythroleukemia in adult mice. The disease proceeds through a two-stage progression (6, 23) . The initial stage of the disease is characterized by the polyclonal expansion of infected cells in bone marrow and the spleen. Because of the interaction of the viral envelope glycoprotein, gp55, with the erythropoietin (Epo) receptor, the induction of leukemia by the virus is specific for the erythroid lineage (16) . The later stage is characterized by the acquisition of new mutations, specifically, the mutation of the p53 gene and proviral insertional activation of Spi1, which leads to the emergence of a leukemic clone (20, 21) . Because of its characteristic staged progression to leukemia and specificity for the erythroid lineage, several host genes that are required for the progression of Friend erythroleukemia have been identified (4, 34) . One group of genes that are required for the initial polyclonal expansion of infected cells has been identified. This group includes the dominant white spotting (W), Steel (Sl), and Friend virus susceptibility gene 2 (Fv2) loci.
The Fv2 locus encodes a naturally occurring truncated form of the Mst1r (also called Stk) receptor tyrosine kinase (29) . This form of the receptor referred to as short-form Stk or Sf-Stk interacts with gp55 and the Epo receptor in infected cells, and Sf-Stk kinase activity is required for the expansion of infected cells in bone marrow (11, 24) . Sf-Stk is expressed from an internal promoter in the Mst1r gene. Mice that are homozygous for the resistant allele of Fv2, Fv2 rr , fail to express Sf-Stk because of a deletion in the Sf-Stk promoter. The W locus encodes the Kit receptor tyrosine kinase, while Sl encodes its ligand, stem cell factor (SCF) (9, 38, 39) . W and Sl mutant mice exhibit multiple phenotypes that include severe macrocytic anemia and pigmentation defects (3, 31) . The SCF/Kit signaling pathway plays a key role in erythroid differentiation by stimulating the proliferation of early erythroid progenitor cells (burst-forming unit-erythroid or BFU-E), leading to the development of late erythroid progenitors (CFU-erythroid or CFU-E) (22) . W mutant mice exhibit near normal levels of early BFU-E but are severely deficient in CFU-E (25) . Early work suggested that the target cell for Friend virus was a late BFU-E (14) . The initial observation that W and Sl mice were resistant to Friend virus suggested that the defect that led to the anemia in these mice was responsible for the resistance (7, 32) . These results underscored the idea that Friend virus required the normal erythroid differentiation machinery for the pathogenesis of erythroleukemia and suggested that the defect in proliferation of BFU-E in W and Sl mice could impair erythropoiesis to such an extent that the mutant mice were resistant to Friend virus-induced erythroleukemia (6, 23) .
To investigate the role of the Kit/SCF signaling pathway in the pathogenesis of Friend virus-induced erythroleukemia, we took advantage of the observation that Friend virus-infected erythroid progenitor cells can form BFU-E and CFU-E colonies in the absence of erythropoietin. In this report we show that W mutant bone marrow cells are sensitive to Friend virus infection both in vitro and in vivo as measured by the formation of Epo-independent (Epo ind ) BFU-E colonies. Furthermore, the number of Friend virus-infected cells in bone marrow is similar to the number in control mice. However, the situation is different in the spleen. In both in vitro and in vivo assays, few Epo ind BFU-E colonies were identified in the spleen, and in fact, BFU-E following Friend virus infection. These data demonstrate that the pathogenic targets of Friend virus in the spleen are distinct from those in bone marrow and suggest that the Kit/SCF signaling pathway is required for development and expansion of Friend virus targets in the spleen. They also underscore the unique nature of the spleen microenvironment in its role in supporting erythropoiesis and the requirement of the spleen for the progression of acute leukemia in Friend virus-infected mice.
MATERIALS AND METHODS
Mice. Eight-to 12-week-old WBB6F1/J-Kit w /Kit w-v (W/W v ) mice, WBB6F1 control mice, and BALB/cJ mice were obtained from the Jackson Laboratory (Bar Harbor, ME). All research involving the use of mice were performed in strict accordance with protocols approved by the Institutional Animal Care and Use Committee of Pennsylvania State University.
Analysis of Stk and Sf-Stk expression by RT-PCR. Expression of Stk and Sf-Stk in bone marrow and spleen cells was determined by reverse transcriptase PCR (RT-PCR). Total RNA was obtained from bone marrow and spleen cells using Trizol (Invitrogen, Carlsbad, CA). Primer sequences were as follows: Stk sense, 5Ј-CAGCAGTGGACAGCCTGTTCA-3Ј; Stk antisense, 5Ј-ATGCCT TCCACTCGGAAGTGC-3Ј; Sf-Stk sense, 5Ј-TCTGGCTGATCCTTCTGT CTG-3Ј; and Sf-Stk antisense, 5Ј-GCAGCAGTGGGACACTTGTCC-3Ј. PCR products were separated on a 1% agarose gel and stained with ethidium bromide. RT parameters were as follows: 70°C for 5 min, 23°C for 10 min, 42°C for 2 min, 42°C for 50 min, 70°C for 15 min, and 37°C for 20 min. RNase H was added prior to the last incubation time. PCR cycling parameters were as follows: 95°C for 5 min; five cycles of 95°C for 45 seconds, 60°C for 1 min, and 72°C for 2 min 30 seconds; and 35 cycles of 95°C for 1 min, 59°C for 1 min, 72°C for 2 min, and 72°C for 10 min.
Colony assay. For in vitro BFU-E formation, total bone marrow and spleen cells were harvested from W/W v and control mice. Supernatant from FP63 cells expressing polycythemia-inducing Friend virus (a kind gift from Alan Bernstein, Mount Sinai Hospital, Toronto, Ontario, Canada) or an equal volume of Dulbecco modified Eagle medium containing 10% fetal bovine serum (mock infection) was incubated with bone marrow or spleen cells (1 ϫ 10 6 cells) on ice for 1 h (bone marrow) or 1 1/2 hours (spleen). For bone marrow assays, the mockinfected cells were plated in Methocult medium (Stem Cell Technologies, Vancouver, British Columbia, Canada) containing interleukin 3 (IL-3) (2.5 ng/ml) plus Epo (1 U/ml). The Friend virus-infected cells were plated in IL-3 (2.5 ng/ml) only. For spleen assays, the mock-infected cells were plated in Methocult medium (Stem Cell Technologies, Vancouver, British Columbia, Canada) containing IL-3 and Epo with and without SCF (100 ng/ml). Friend virus-infected spleen cells were plated in Methocult medium containing IL-3 with and without SCF (100 ng/ml). For in vivo analysis of Friend virus-infected bone marrow and spleen cells, W/W v and control mice were injected intravenously with Friend virus. On the indicated days, spleen and bone marrow cells were harvested and plated in Methocult medium (Stem Cell Technologies, Vancouver, British Columbia, Canada). Bone marrow cells were plated in IL-3 with and without Epo at the concentrations indicated above. Spleen cells were plated in IL-3 with and without Epo or in IL-3 plus SCF with and without Epo at the concentrations indicated above. The cultures were scored for BFU-E as previously described (11) .
Flow cytometry. W/W v and control mice were injected intravenously with Friend virus. On days 0, 4, 8, and 12 postinfection, bone marrow and spleen cells were isolated. Cells were stained with either monoclonal antibody MAb34, which is specific for Friend murine leukemia virus glycosylated Gag protein and stains both Friend murine leukemia virus-and spleen focus-forming virus-infected cells (10) (provided by K. Hasenkrug, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases) alone or in combination with R-phycoerythrin-conjugated rat anti-mouse TER-119 (Ly-76) (Pharmingen, San Diego, CA). MAb34 was detected by fluorescein isothiocyanate-conjugated goat antimouse immunoglobulin G2b (Caltag Laboratories, Burlingame, CA), which was preabsorbed on spleen cells of C57BL/6 mice prior to use as previously described (36) . Expression of surface antigens was analyzed using a Beckman Coulter flow cytometer. Isolation of MEPs from bone marrow and spleen was done as described previously (2) .
Infection of mice with Friend virus. W/W v and control mice were infected as previously described (28) . Mice were sacrificed, and spleens were removed on the designated dates. The spleen was weighed with an analytical balance and measured in grams. (Fig. 2 ). These results demonstrate that the initial number of Friend virus target cells and the expansion of Friend virus-infected cells during infection in bone marrow do not require the Kit/SCF signaling pathway.
W/W v mice have a defect in Friend virus target cells in the spleen.
In addition to bone marrow, the spleen is also a major site of Friend virus infection in wild-type mice. Indeed, the expansion of infected erythroblasts in the spleen leads to splenomegaly, one of the hallmarks of Friend virus infection (6, 23) . In order to test whether W/W v mice had a defect in Friend virus target cells in the spleen, spleen cells isolated from W/W v and control mice were infected in vitro to determine whether they could form Epo ind BFU-E. Control spleen cells exhibited very modest Epo ind BFU-E formation when plated with IL-3 in the medium; however, when SCF was added (100 ng/ml), the number of Epo ind BFU-E was approximately equal to the number of BFU-E observed in the cultures that contained Epo (Fig. 3A) . In contrast, the W/W v cells exhibited a marked reduction in the number of BFU-E in the cultures containing Epo, which increased when SCF was included in the medium. However, the W/W v cells gave rise to very few Epo ind BFU-E, and this number was not increased by the inclusion of SCF in the medium (Fig. 3B) . Therefore, unlike bone marrow, the spleens of W/W v mice contain very few target cells that can be productively infected by Friend virus.
We next analyzed the expansion of infected cells in the spleens of W/W v and control mice. The mice were infected with Friend virus, and spleen cells were isolated at 0, 2, 4, and 6 days postinfection. The spleen cells were plated out in medium containing IL-3 with or without Epo or IL-3 plus SCF with or without Epo. In the control spleens, the expansion of Epo ind BFU-E was slower than the expansion observed in bone marrow (Fig. 4A) . By day 2 postinfection, the number of Epo ind BFU-E in bone marrow was significantly greater than in uninfected mice, while in the spleen a significant increase in Epo ind BFU-E was not observed until day 6 postinfection. Furthermore, the addition of Epo significantly increased the number of BFU-E observed. cells, no expansion of Epo ind BFU-E was observed at any time point and the addition of Epo did not significantly increase the number of BFU-E (Fig. 4B) mice suggests that either mutation of the Kit receptor in these mice impairs the Epo ind expansion and differentiation mediated by Friend virus infection or they lack pathogenic target cells in the spleen. We analyzed the percentage of Friend virus-infected cells in bone marrow and the spleen during the course of infection by flow cytometry. We used MAb34, which recognizes the Gag protein of Friend virus and has been used previously to follow infected cells during infection (10, 36) . W/W v and control mice were infected with Friend virus, and bone marrow and spleen cells were isolated and stained with MAb34. In the control mice, the percentage of MAb34 ϩ cells in bone marrow starts to increase on day 4, peaks at day 8, and by day 12 has decreased. In the W/W v mice, the infection of cells in bone marrow proceeds in a manner similar to control mice; however, the percentage of infected cells is slightly less than control mice at day 8 and decreases further on day 12 (Fig. 5A) . In the spleens of control mice, the infection starts to increase on day 4 but continues to increase so that by day 12, Ͼ90% of the spleen cells are MAb34 ϩ . The most striking difference in the W/W v mice is in the spleen where few cells are infected and the Friend virus-infected cells do not increase over time (Fig. 5B) . Staining with MAb34 identifies all cells infected with Friend virus; in order to track infected cells of the erythroid lineage, we repeated the flow cytometry analysis except this time we double stained the cells with MAb34 and an antibody against TER119 that recognizes late erythroid progenitors (13 . These results were reflected in the splenomegaly observed in the control mice ( Fig. 5D and E) . In contrast to the spleens of control mice, we observed that very few of the MAb34 ϩ cells were TER119 ϩ cells in the spleens of W/W v mice, which correlated with the complete lack of splenomegaly in these mice ( Fig. 5D and E Kit ؉ megakaryocyte-erythroid progenitors are Friend virus target cells in the spleen, but not in bone marrow. Given that mutations in the Kit receptor severely decrease the number of Friend virus target cells in the spleen, we next analyzed Kit ϩ subpopulations of spleen cells for Friend virus target cells using the in vitro infection assay. Analysis of erythroid progenitors in the bone marrow showed that two distinct Kit ϩ subpopulations, the common myeloid progenitor and the megakaryocyte-erythroid progenitor give rise to BFU-E in culture (2) . We have shown that only MEPs are present in the spleen (15) . We tested whether MEPs isolated from the spleens of control mice could form Epo ind BFU-E colonies following Friend virus infection in vitro. Figure 8A shows that spleen MEPs efficiently form Epo ind BFU-E following infection with Friend virus. Interestingly, bone marrow MEPs fail to form Epo ind BFU-E colonies in this assay. These results demonstrate that MEPs, a population of Kit ϩ erythroid progenitors in the spleen, are the pathogenic targets for Friend virus. Furthermore, this target cell population in the spleen is distinct from the bone marrow target cell population.
Taken together, all the data we have presented suggests that W/W v mice lack target cells in the spleen. However, it is possible that the defect in W/W v mice is not in the number of targets but in the ability of these cells to respond to infection. To differentiate between these possibilities, we compared the numbers of MEPs in the spleens of W/W v and control mice by flow cytometry. In four independent experiments, the percentage of MEPs (Lin Ϫ Sca1 Ϫ IL-7R␣ Ϫ CD34 Ϫ Kit ϩ Fc␥R low in the spleen was approximately 10-fold lower than in the controls (Fig. 8B) . Calculation of the absolute number of MEPs per spleen showed a consistent 4.5-to 5. 
DISCUSSION
Friend virus induces erythroleukemia by co-opting the erythroid differentiation machinery. The Kit/SCF signaling pathway regulates the expansion of erythroid progenitors and is thought to function primarily during the transition from BFU-E to CFU-E (25) . Because of the severe anemia exhibited by the W and Sl mutant mice, it was proposed that this defect in erythropoiesis was the cause of the resistance to Friend virus in these mice (6) . In this report we show that the role of the Kit/SCF signaling pathway in Friend virus pathogenesis is more complex. Our data show that the resistance of W/W v mice is caused by a defect specific to the spleen. These mice exhibit very few Friend virus targets in the spleen, which lack Sf-Stk expression, while the number of target cells in the bone marrow is similar to control mice.
More than 40 years ago, work from Mirand and colleagues showed that the spleen provided a microenvironment that favored the expansion of Friend virus-infected cells (19) . Splenectomized mice exhibit a pronounced delay in the development of polycythemia and leukocytosis after infection despite the observation that the splenectomized mice exhibited significant expansion of erythroblasts in the bone marrow. These results demonstrated that the spleen, not the bone marrow, is the primary organ for Friend virus-induced expansion of erythroid progenitors. In the absence of the spleen, mice will eventually develop polycythemia and leukemia after long la- tency; however, the liver becomes the primary site for Friend virus pathogenesis in these mice (18) . It is not surprising that the spleen plays a key role in the expansion of Friend virus-infected cells. The spleen provides a supportive microenvironment for erythropoiesis. Similar to fetal liver stromal cells, mouse spleen stromal cells are able to support the expansion of early erythroid progenitor cells, whereas bone marrow stromal cells cannot (26, 27, 37) . The spleen is also the site of expansive erythropoiesis associated with the recovery from acute anemia or hypoxia. We have shown that acute anemia induces the rapid expansion of a novel stress erythroid progenitor, the stress BFU-E, which requires the BMP4 signaling pathway (15) . In addition, our work showed that spleen MEPs are the BMP4-responsive cells in the spleen. Early work in the field showed that W and Sl mice are slow to recover from phenylhydrazine (PHZ)-induced acute hemolytic anemia (12) , and we have observed defects in the expansion of stress BFU-E in W/W v mice during the recovery from PHZ-induced acute anemia (J. Perry and R. On the basis of our observations, the Kit/SCF signaling pathway may play two roles in the pathogenesis of Friend virus. The W/W v mice exhibit a clear deficit in target cells in the spleen as measured by in vitro and in vivo assays for Epo ind BFU-E and flow cytometry analysis of MEPs and infected cells. These results suggest that the Kit/SCF pathway is required for the development or expansion of MEPs in the spleens of healthy mice. In addition to this role, Kit may also be involved in the expansion of Friend virus-infected cells. We observed that inclusion of SCF in the medium greatly facilitated the development of Epo ind BFU-E in control spleen cells infected in vitro with Friend virus. These results are similar to those reported by Quang and coworkers using a chicken erythroblast system. They showed that Kit/SCF-dependent signaling induced extensive proliferation in cells that expressed an activated Epo receptor and Spi-1, which suggested that Kit signaling cooperates with the genetic events induced by Friend virus to promote the expansion of infected cells (30) . These studies showed that Spi-1 expression was required for the Kit/SCF-dependent increase in proliferation, but this conclusion is complicated by the observation that overexpression of Spi-1 due to proviral insertion is a relatively late event in the pathogenesis of Friend erythroleukemia. Recent work that demonstrated that gp55-dependent signaling activates the expression of Spi-1 even at early times during infection removes this complication (1 
